CTRI/2019/07/020247招募中未知
A Randomized controlled trial of efficacy and Safety of Hemoperfusion or Plasma Exchange compared to standard medical therapy in patients With acute on chronic liver failure.
试验速览
- 阶段
- 未知
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Patients diagnosed with ACLF as per APASL criteria will be included.
- •2) Age : 18-65 yrs.
排除标准
- •1) Patient with ischemic heart disease
- •2) Patient with chronic obstructive disease.
- •3) Patient with hepato cellular carcinoma.
- •4) Patient with extra hepatic malignancy.
- •5) Patient with chronic renal insufficiency.
研究者
相似试验
进行中（未招募）
不适用
The efficacy and safety of Ninjin'yoeito for anorexia, apathy in dementia.Anorexia in dementia with apathyDementia/Anorexia/ApathyJPRN-jRCTs031200079Arai Tetsuaki120
招募中
4 期
A clinical trial to study the efficacy and safety of two drugs ferric carboxymaltose and iron sucrose complex in the treatment of iron deficiency anemia in patients with gynaecological disorders.CTRI/2014/03/004461ady Hardinge Medical College60
尚未招募
不适用
Study of Saroglitazar in Type 2 Diabetis MellitusCTRI/2021/04/032550AIIMS Jodhpur
进行中（未招募）
1 期
Randomized Trial to Evaluate the Efficacy and Safety of Cinacalcet Treatment in Combination with Low Dose Vitamin D for the Treatment of Subjects with Secondary Hyperparathyroidism (SHPT) Recently Initiating Hemodialysis._____________________________________________Estudio aleatorizado para evaluar la eficacia y seguridad del tratamiento con cinacalcet en combinación con bajas dosis de vitamina D para el tratamiento de pacientes con hiperparatiroidismo secundario (HPTS) incidentes en diálisis.Treatment of secondary hyperparathyroidism (SHPT)_______________________________________________Tratamiento del hiperparatiroidismo secundario (HPTS)MedDRA version: 9.1Level: LLTClassification code 10020708Term: Hyperparathyroidism secondaryEUCTR2008-004558-34-ESAmgen Inc300
进行中（未招募）
不适用
Randomized Trial to Evaluate the Efficacy and Safety of Cinacalcet Treatment in Combination with Low Dose Vitamin D for the Treatment of Subjects with Secondary Hyperparathyroidism (SHPT) Recently Initiating HemodialysisTreatment of secondary hyperparathyroidism (SHPT)MedDRA version: 9.1Level: LLTClassification code 10020708Term: Hyperparathyroidism secondaryEUCTR2008-004558-34-BEAmgen Inc300